HekaHeart Honored as Best Business at AHA Health Tech Competition 2024
This past weekend, HekaHeart participated in the 2024 AHA Health Tech Competition at the American Heart Association Scientific Sessions in Chicago. Selected as one of the finalists from a record number of applicants, we were excited to showcase our Virtual-First Heart Failure Clinic, which is transforming heart failure care through remote medication optimization and volume management, real-time monitoring, and personalized care plans.
HekaHeart was awarded Best Business, a recognition that underscores the strength of our platform in delivering both clinical and operational value. This award highlights the impact of our work in improving patient outcomes and empowering clinicians, while also driving financial performance.
"This is exactly the type of innovation we need in cardiovascular care," said Dr. Marat Fudim, an Advanced Heart Failure Specialist at Duke University and one of the competition judges. "HekaHeart combines advanced technology with clinical expertise to enhance access, optimize outcomes, and deliver measurable value to practices and providers."
A Milestone Moment
The AHA Health Tech Competition showcases innovation in cardiovascular care. Competing alongside some of the most innovative companies in the field, we are honored to have our vision recognized.
This marks an important step in our journey to expand access to advanced heart failure care and transform how this complex condition is managed.
Transforming Heart Failure Care
HekaHeart enables practices and systems to deliver specialist-level care without increasing provider burden. Through AI-driven insights, remote monitoring, and a multidisciplinary clinical team, we prescribe and manage tailored medication regimens and deliver high-quality care between local visits. Our model enhances outcomes, drives financial performance by unlocking new reimbursable services and improving quality metrics, and practice efficiency by reducing time spent on high-need, complex patients.
What's Next for HekaHeart?
This recognition motivates us to continue advancing care for the 1 million US patients newly diagnosed with heart failure each year and over 6.5 million patients living with the condition. We look forward to partnering with cardiology practices and health systems nationwide to scale our platform and improve the lives of so many patients in need.
A Heartfelt Thank You
We are grateful to the American Heart Association for this opportunity and to the providers, patients, and partners who work alongside us and support our journey. Together, we are making a significant impact in heart failure care.
